click below
click below
Normal Size Small Size show me how
Txn Diseases
Transfusion Associated Disease
| Question | Answer |
|---|---|
| Which blood component poses the highest risk of bacterial contamination and sepsis, and why? | Platelets, because they are stored at room temperature (20-24C, which promotes rapid bacterial proliferation. |
| What are two common bacterial contaminants found in room-temperature stored platelet concentrates? | Staphylococcus epidermidis and Bacillus cereus (or skin flora contaminants). |
| Why is the risk of transfusion-transmitted syphilis extremely low in modern blood banking? | The causative spirochete (Treponema pallidum) is sensitive to cold and generally cannot survive in red blood cells stored at 4Cfor more than 48–72 hours. |
| What tick-borne parasite is one of the most commonly reported transfusion-transmitted parasites in the U.S.? | Babesia microti (diagnosed via thick/thin blood smears). |
| How long can Trypanosoma cruzi (Chagas disease) persist in a human host's latent phase before detection or donation? | Up to 40 years. |
| Why are blood centers unable to use a universal high-throughput screening test for malaria in all donor units? | Because universal direct laboratory screening tests are lacking; centers must rely instead on travel history and donor deferral questionnaires. |
| What unconventional infectious agent causes Creutzfeldt-Jakob Disease (CJD)? | A prion (an abnormally folded protein that induces normal brain proteins to misfold). |
| How is the blood supply protected against variant CJD (vCJD) given that no validated large-scale screening test exists for donors? | By strict donor history questionnaires (screening for family history, brain/dura mater grafts, human pituitary growth hormone, or travel/residence in Europe during BSE outbreaks). |
| What confirmatory assays are traditionally used alongside screening assays for supplemental HIV testing? | Western Blot, Radioimmunoprecipitin Assay (RIPA), or Immunofluorescence assays (IFA). |
| What three mandatory markers are tested to screen for Hepatitis B (HBV) in blood donations? | Hepatitis B surface antigen HBsAg, total antibody to hepatitis B core anti-HBc, and HBV DNA via Nucleic Acid Testing (NAT). |
| Which specific Hepatitis B marker is the very first to appear in the bloodstream following infection? | HBV DNA (detected via PCR). |
| What clinical condition is indicated by the presence of IgM anti-HBc in a patient or donor? | A current or recent acute hepatitis B infection. |
| What does the presence of HBsAg indicate regarding infectiousness and duration? | It indicates that the person is infectious; high levels persist in chronic infections (>6 months). |
| What does the presence of Anti-HBs indicate in an individual's lab profile? | Immunity to Hepatitis B, resulting from either past resolved infection or vaccination. |
| What is the initial screening test performed for Hepatitis C (HCV), and what does a positive result indicate? | Anti-HCV Enzyme Immunoassay (EIA). A positive result indicates past exposure, but it cannot differentiate between an active infection and a resolved past infection. |
| What confirmatory test must follow a reactive Anti-HCV screening test to confirm an active infection? | HCV RNA via Nucleic Acid Testing (NAT). |
| Why can Hepatitis D (HDV) only replicate in the presence of Hepatitis B? | HDV is a defective single-stranded RNA virus that specifically requires the Hepatitis B surface antigen HBsAg to synthesize its own envelope protein. |
| Why do blood centers not routinely perform standalone screening tests for Hepatitis D (HDV)? | Because HDV cannot exist without HBV, eliminating all units that test positive for HBV automatically protects the blood supply from HDV. |
| What is Hepatitis G (GBV-C / HPgV), and why is it not routinely screened for in blood banks? | It is a bloodborne RNA virus related to HCV, but it has no conclusive link to liver disease or any clinical illness; therefore, routine screening is not required by health organizations. |
| What are the primary cell surface targets for HIV-1 and HIV-2 upon initial infection? | CD4+ lymphocytes, macrophages, and antigen-presenting cells. |
| What dual testing approach is used by blood centers to screen donor units for HIV? | anti-HIV 1/2 antibody testing (EIA) combined with HIV-1 RNA Nucleic Acid Testing (NAT) to shorten the window period. |
| What specific CD4+ T-cell count threshold is used to clinically diagnose AIDS in an HIV-positive patient? | A CD4+ count dropping below 200/muL |
| How are HTLV-I and HTLV-II primarily transmitted through biological routes? | Through the introduction of living, infected white blood cells (WBCs), such as via breastfeeding, sexual contact, or parenteral exposure (transfusions and needle sharing). |
| What severe malignancy is specifically associated with HTLV-I infection? | Adult T-cell Lymphoma/Leukemia (ATL), an aggressive cancer with a mean survival rate of less than one year. |
| Which blood component poses the highest risk of bacterial contamination and transfusion-related sepsis, and why? | Platelets, because they are stored at room temperature (20°C–24°C), which promotes rapid bacterial proliferation |
| What are two common bacterial contaminants found in platelet concentrates? | Staphylococcus epidermidis and Bacillus cereus (often introduced from skin flora during collection). |
| Which bacterial organism is a well-known contaminant of refrigerated Red Blood Cell (RBC) units? | Yersinia enterocolitica (along with Pseudomonas species, Staphylococcus epidermidis, and Bacillus cereus). |
| What triggers a "look-back" and reporting process in blood banking? | When a donor subsequently tests positive for an infectious disease or a recipient is found to have developed an infection after receiving a transfusion. |
| What immediate action must be taken regarding in-date blood components from a donor who tests positive for HBV, HCV, HIV, or HTLV? | The components must be immediately quarantined, with their final disposition determined by licensed confirmatory testing. |
| What federal agency must be notified of any transfusion-related fatality, and what is the initial reporting timeline? | The Center for Biologics Evaluation and Research (CBER), with an initial report required within 1 working day (followed by a detailed written report within 7 days). |
| Under what conditions is a blood donor permanently deferred during a look-back investigation? | A donor is permanently deferred if a patient develops HBV, HCV, HIV, or HTLV after receiving a single unit from that donor. |
| Can autologous units (donated for the patient's own use) that test positive for syphilis, HBV, HCV, HIV, or HTLV still be used? | Yes, they may still be used for that specific patient, provided the transfusion service/receiving facility is notified, repeat testing is performed every 30 days for shipped units, and both the patient and physician are informed. |